ProShares MSCI Transformational Changes ETF ANEW
54.66 USD -0.02 (-0.04%)
Oct 12, 2026, 9:46 AM EDT
54.66 Day range 54.66
54.66 52-week range 54.66
- YTD
- -0.05%
- 1 year
- -0.05%
- Market cap
- 8.16M
- EPS (ttm)
- 2.20
- P/E ratio
- 24.82
- YTD return
- -0.05%
- 1-year return
- -0.05%
- Volume
- 7
- Avg volume
- 7
- Open
- 54.66
- Previous close
- 54.68
- Day's range
- 54.66 – 54.66
- 52-week range
- 54.66 – 54.66
No chart data for this range yet.
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 46.04
- 200-day average
- 43.09
About ProShares MSCI Transformational Changes ETF
The fund invests in financial instruments that ProShare Advisors believes, in combination, should track the performance of the index. The index is designed to measure the performance of companies associated with one or more of the following themes: Future of Work, Digital Consumer, Genomic & Telehealth, and Food Revolution. Under normal circumstances, it will invest at least 80% of its total assets in components of the index or in instruments with similar economic characteristics.
News
How Policy, Geopolitics And AI Are Reshaping Markets 
AI's Biggest Gainers 
Davos 2025: ETFs To Tackle Geopolitical, Climate, Cyber Risks 
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc. 
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc. 
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy 
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy 
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility - ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
Your note
Sign in to keep a note on ANEW — it syncs with the Stock Master app.